Quick Takeaways
- This page summarizes Christopher B. Ehrlich's Form 4 filing for eFFECTOR Therapeutics, Inc..
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 08 Oct 2021, 17:22.
Christopher B. Ehrlich - 06 Oct 2021 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.
- Role
- Director
- Signature
- /s/ Michael Byrnes, Attorney-in-Fact for Christopher B. Ehrlich
- Issuer symbol
- N/A
- Transactions as of
- 06 Oct 2021
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 08 Oct 2021, 17:22:23 UTC
- Previous filing
- 05 Oct 2021
- Next filing
- 12 Oct 2021
- SEC
- View on sec.gov
Quoteable Key Fact
"Christopher B. Ehrlich filed Form 4 for eFFECTOR Therapeutics, Inc. on 08 Oct 2021."
What Changed
- Previous filing in this sequence was filed on 05 Oct 2021.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EFTR | Stock Option (Right to Buy) | Award | $0 | +40,000 | $0.000000 | 40,000 | 06 Oct 2021 | Common Stock | 40,000 | $11.36 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The shares subject to the option will vest in substantially equal monthly installments over three years, commencing on August 25, 2021, subject to the Reporting Person's continued service with the Issuer through each vesting date. |